Βk-2C-I
Βk-2C-I is a synthetic psychedelic compound that belongs to the phenethylamine class of drugs. It is structurally related to the well-known psychedelic 2C-I, with the addition of a beta-ketone group. This modification places Βk-2C-I in the category of beta-ketone phenethylamines, which are sometimes referred to as "bk-2C" compounds.
Chemical Structure and Properties
Βk-2C-I, or beta-keto 2C-I, is chemically known as 2-(4-iodo-2,5-dimethoxyphenyl)-2-(methylamino)propan-1-one. The presence of the beta-ketone group distinguishes it from its parent compound, 2C-I, which is 2,5-dimethoxy-4-iodophenethylamine. The addition of the ketone group is thought to affect the compound's pharmacokinetics and pharmacodynamics.
Molecular Formula: C11H14INO3
Molecular Weight: 335.14 g/mol
Pharmacology
Βk-2C-I is believed to act as a serotonin receptor agonist, similar to other phenethylamine psychedelics. It likely exerts its effects primarily through the 5-HT2A receptor, which is known to play a significant role in the psychedelic experience. However, detailed studies on its receptor binding profile and pharmacological effects are limited.
Effects
The effects of Βk-2C-I are reported to be similar to those of 2C-I, including altered sensory perception, visual hallucinations, and changes in thought processes. Users have described experiences of enhanced colors, patterns, and a sense of euphoria. The onset of effects typically occurs within 30 to 60 minutes after ingestion, with a duration of action lasting 4 to 8 hours.
Safety and Toxicity
As with many research chemicals, the safety profile of Βk-2C-I is not well-established. There is limited data on its toxicity, potential for abuse, and long-term health effects. Users should exercise caution and be aware of the potential risks associated with its use.
Legal Status
The legal status of Βk-2C-I varies by country. In some jurisdictions, it may be classified as a controlled substance, while in others it may be unscheduled. It is important for individuals to be aware of the legal implications of possessing or using Βk-2C-I in their region.
History and Research
Βk-2C-I is a relatively new compound in the realm of synthetic psychedelics. It emerged in the early 21st century as part of the wave of novel psychoactive substances (NPS) that have been synthesized and distributed, often via online markets. Research on Βk-2C-I is limited, and much of the available information comes from anecdotal reports and user experiences.
Also see
| Phenethylamines | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD